Alton Gregg H decreases stake in Gilead Sciences, Inc. (NASDAQ:GILD) with selling 50000 shares worth of $3950000
Gilead Sciences, Inc. (NASDAQ:GILD) closed the trading with positive move of +0.05% and finish the day at $83.75 which had been above its previous day’s closing of $83.71. The firm has price to sales ratio of 3.84 and its price to book per share was 4.82. The stock is trading higher its 50-day moving averages of 74.38 and above 200-day moving averages of 69.29. The shares registered one year high of $84.13 and one year low was seen at $63.76.
Shares of the company registered a buying and selling volume of 14.31 million shares higher than its 3-months average volume of 9.77 million shares and traded in range of $82.25 to $84.10.
Recent Insider Selling Activity:
Currently the Insiders own 0.30% of Gilead Sciences, Inc. shares. Institutional Investors own 77.40% of company’s shares. During last three month period, the net percent change held by Institutional Investors has seen a change of 0.55%. During last six month period, the net percent change kept by insiders has seen a change of -11.34%.
In the company’s insider trading activities, Alton Gregg H; EVP Comm&Acs ALA, Corp&Med Aff of Gilead Sciences, Inc. sold 50000 shares worth of $3950000 in a transaction on 30 Aug 2017. In this transaction, these shares were sold at value of $79 per share, according to the information disclosed by the Securities and Exchange Commission in a Form 4 filing on 01 Sep 2017.
Alton Gregg H; EVP Comm&Acs ALA, Corp&Med Aff of Gilead Sciences, Inc. also sold 15000 shares worth of $1138190 in a transaction dated on 01 Aug 2017. Shares were sold at the average price of 75.88 per share, according to SEC Form 4 filing submitted on 03 Aug 2017.
In other transaction, MARTIN JOHN C (Executive Chairman) sold 73333 shares on 01 Aug 2017 worth of $5562777. In this Insider Trading activity, shares were sold with per share cost of $75.86.